Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer — RAD 1702

Locally Advanced Head and Neck Cancer Clinical Trial

Official title:
Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer

Status Completed

Clinical Trial Summary

To confirm the feasibility of studying Xtampza ER during radiotherapy (RT) for LAHNC as part of a prospective clinical trial.

Clinical Trial Description

To confirm the feasibility of studying Xtampza ER during radiotherapy (RT) for locally advanced head and neck cancer (LAHNC) as part of a prospective clinical trial. Investigators will also assess pain control, quality of life, and drug related toxicity during RT and during short term follow-up. ;

Study Design

Related Conditions & MeSH terms

Head and Neck Neoplasms
Locally Advanced Head and Neck Cancer

Clinical Trial Details

NCT number	NCT03317730
Study type	Interventional
Source	University of Alabama at Birmingham
Contact
Status	Completed
Phase	Early Phase 1
Start date	May 1, 2018
Completion date	November 17, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03532737` - Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer	Phase 2
Completed	`NCT01969877` - A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.	Phase 3
Recruiting	`NCT01212354` - Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT	Phase 3
Recruiting	`NCT02976051` - DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC	Phase 2
Active, not recruiting	`NCT03699969` - A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer	N/A